Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Rheumatology (Oxford, England)
|
July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
Dong Xu, Jianmin Fang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases
|
April 17, 2025
The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis
Xinzhuang Yang, Chen Yu, Xiuling Zhang, et al.
Rheumatology and Immunology Research
|
April 13, 2026
Community-based epidemiological study on the prevalence and health status of Spondyloarthritis in residents of Wuyuan County, China, 2023
Shichao Yu, Xiuling Zhang, Zhijie Liu, et al.
Innovation (Cambridge (Mass.))
|
August 15, 2025
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Advances in Therapy
|
May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial
Zaihua Zhu, Yu Xue, Tianshu Chu, et al.
Chinese Medical Journal
|
April 10, 2023
Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
Fan Yang, Chaofan Lu, Huilan Liu, et al.
Clinical Rheumatology
|
June 7, 2025
Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendations
Wei Bai, Yinli Gui, Jia Liu, et al.
International Journal of Rheumatic Diseases
|
January 18, 2025
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate-To-Severe Disease Activity - A Multicenter Cohort Study of Treatment Strategies and Outcomes
Yafang Deng, Lin Qiao, Hongbin Li, et al.
International Journal of Rheumatic Diseases
|
July 10, 2023
Chinese Registry of Psoriatic Arthritis (CREPAR): I. Clinical characteristics of Chinese patients with psoriatic arthritis
Chaofan Lu, Fan Yang, Huilan Liu, et al.
Rheumatology and Therapy
|
August 20, 2025
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial
Ning Kong, Yu Xue, Li Mao, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Rheumatology (Oxford, England)
|
July 3, 2023
Efficacy and safety of telitacicept in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
Dong Xu, Jianmin Fang, Shangzhu Zhang, et al.
Annals of the Rheumatic Diseases
|
April 17, 2025
The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis
Xinzhuang Yang, Chen Yu, Xiuling Zhang, et al.
Rheumatology and Immunology Research
|
April 13, 2026
Community-based epidemiological study on the prevalence and health status of Spondyloarthritis in residents of Wuyuan County, China, 2023
Shichao Yu, Xiuling Zhang, Zhijie Liu, et al.
Innovation (Cambridge (Mass.))
|
August 15, 2025
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
Yu Xue, Tianshu Chu, Jiankang Hu, et al.
Advances in Therapy
|
May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial
Zaihua Zhu, Yu Xue, Tianshu Chu, et al.
Chinese Medical Journal
|
April 10, 2023
Enthesitis in patients with psoriatic arthritis: A nationwide data from the Chinese Registry of Psoriatic Arthritis (CREPAR)
Fan Yang, Chaofan Lu, Huilan Liu, et al.
Clinical Rheumatology
|
June 7, 2025
Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendations
Wei Bai, Yinli Gui, Jia Liu, et al.
International Journal of Rheumatic Diseases
|
January 18, 2025
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate-To-Severe Disease Activity - A Multicenter Cohort Study of Treatment Strategies and Outcomes
Yafang Deng, Lin Qiao, Hongbin Li, et al.
International Journal of Rheumatic Diseases
|
July 10, 2023
Chinese Registry of Psoriatic Arthritis (CREPAR): I. Clinical characteristics of Chinese patients with psoriatic arthritis
Chaofan Lu, Fan Yang, Huilan Liu, et al.
Rheumatology and Therapy
|
August 20, 2025
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial
Ning Kong, Yu Xue, Li Mao, et al.
Page
of 8